with glucocorticoids, thyroid hormones and gonadal steroids were studied with respect to known risk factors for cardiovascular disease. For comparison, data from a population study, "the MONICA study", were obtained. The patients had a significantly higher body mass index compared to controls (p<0.001). Serum Adrenal, thyroid and gonadal functions were assessed with the laboratory tests available at the time, as described previously (1) . Growth (Table 3 ). There were fewer smokers (p < 0.001 ) among the patients (Table 4 ). Body mass index was higher (p< 0.001) in patients compared to controls, but the systolic and diastolic blood pressures did not differ ( Table 3) .
As expected, serum total cholesterol concentrations increased with age in both the patients and the control men and women, but there was no difference between the patients and the controls (Table 5) . Also, serum triglycéride concentration increased with age in the control subjects ( The serum triglycéride concentration is higher in both male (p<0.01) and female (p<0.01 ) patients compared to controls. (12) .
There are only a few reports on changes in serum lipids and Iipoproteins in GH deficiency in adults.
Merimee and co-workers found that GH-deficient sub¬ jects with hyperlipidemia had greater elevation of their serum lipids compared to non-GH-deficient members of their families (13, 14) . Growth hormone treatment of GH-deficient adults for 6 months resulted in a decrease in cholesterol concentrations but no change in triglycéride concentrations were noted (15) . However We found that the triglycéride concentrations were increased in the GH-deficient subjects, which is in agreement with the findings that hypertriglyceridemia was more common among GH-deficient patients (13, 14) . In the study by Salomon et al. (15) (15, 18) . These effects are ascribed to the lipolytic, anabolic and antinatriuretic effects of GH (19) (20) (21) . We found that GH-deficient subjects had an increase in BM1, which can be ascribed to increased body fat (9) and especially visceral fat (18) .
Growth hormone treatment of GH-deficient adults de¬ creases body fat, and the loss of visceral fat is more pronounced than that of other fat depots (18) . Because visceral adiposity in itself is associated with increased triglycéride concentrations and decreased HDL concen¬ trations (22) (24) (25) (26) . No 
